-
EP2461835
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2461835
| EP2461835 - COMPOSITIONS CONTAINING JARID1B INHIBITORS AND METHODS FOR TREATING CANCER [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 08.07.2016 Database last updated on 02.11.2024 | Most recent event Tooltip | 08.07.2016 | Application deemed to be withdrawn | published on 10.08.2016 [2016/32] | Applicant(s) | For all designated states The Wistar Institute 3601 Spruce Street Philadelphia, PA 19104-4268 / US | [2012/24] | Inventor(s) | 01 /
ROESCH, Alexander, O. Bogenstrasse 13 66424 Homburg-Beeden / DE | 02 /
HERLYN, Meenhard 1223 Knox Road Wynnewood PA 19096 / US | [2012/24] | Representative(s) | Hally, Anna-Louise, et al FRKelly 27 Clyde Road Dublin D04 F838 / IE | [N/P] |
| Former [2012/24] | Hally, Anna-Louise, et al FRKelly 27 Clyde Road Dublin 4 / IE | Application number, filing date | 10807205.9 | 06.08.2010 | WO2010US44643 | Priority number, date | US20100329782P | 30.04.2010 Original published format: US 329782 P | US20090232069P | 07.08.2009 Original published format: US 232069 P | [2012/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011017583 | Date: | 10.02.2011 | Language: | EN | [2011/06] | Type: | A1 Application with search report | No.: | EP2461835 | Date: | 13.06.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.02.2011 takes the place of the publication of the European patent application. | [2012/24] | Search report(s) | International search report - published on: | US | 10.02.2011 | (Supplementary) European search report - dispatched on: | EP | 15.04.2013 | Classification | IPC: | A61K51/00, A61M36/14, A61K31/7105, A61K38/17 | [2013/20] | CPC: |
A61K45/06 (EP,US);
A61K31/7105 (EP,US);
A61K38/1709 (EP,US);
A61P35/00 (EP);
A61P35/04 (EP)
| C-Set: |
A61K31/7105, A61K2300/00 (EP,US)
|
| Former IPC [2012/24] | A61K51/00, A61M36/14 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/24] | Title | German: | ZUSAMMENSETZUNGEN MIT JARID1B-HEMMERN UND VERFAHREN ZUR BEHANDLUNG VON KREBS | [2012/24] | English: | COMPOSITIONS CONTAINING JARID1B INHIBITORS AND METHODS FOR TREATING CANCER | [2012/24] | French: | COMPOSITION CONTENANT DES INHIBITEURS DE JARID1B ET MÉTHODES DE TRAITEMENT DU CANCER | [2012/24] | Entry into regional phase | 07.03.2012 | National basic fee paid | 07.03.2012 | Search fee paid | 07.03.2012 | Designation fee(s) paid | 07.03.2012 | Examination fee paid | Examination procedure | 07.03.2012 | Examination requested [2012/24] | 17.10.2013 | Amendment by applicant (claims and/or description) | 01.03.2016 | Application deemed to be withdrawn, date of legal effect [2016/32] | 01.04.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2016/32] | Fees paid | Renewal fee | 23.10.2012 | Renewal fee patent year 03 | 19.08.2013 | Renewal fee patent year 04 | 13.08.2014 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.08.2012 | 03 M06 Fee paid on 23.10.2012 | 31.08.2015 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [E]WO2010095364 (ONCOTHERAPY SCIENCE INC [JP], et al) [E] 1,4,5,8,9,12,15 * paragraphs [0078] , [0082] *; | [XY]CN101239181 ; | [XY]US2008319025 (SELLERS EDWARD M [CA], et al) [X] 8 * page 4, paragraphs 67-68,147; claims 4-6 * [Y] 6,7,12-14; | [XY] - DATABASE WPI, 0, Derwent World Patents Index, vol. 2008, no. 73, Database accession no. 2008-M35724, XP002694842 & CN101239181 A 20080813 (SHANGHAI INST BIOLOGICAL SCI) [X] 5,8 * abstract * [Y] 1-4,6,7,9-15 | [Y] - D. S. HILL ET AL, "Combining the Endoplasmic Reticulum Stress-Inducing Agents Bortezomib and Fenretinide as a Novel Therapeutic Strategy for Metastatic Melanoma", CLINICAL CANCER RESEARCH, (20090215), vol. 15, no. 4, doi:10.1158/1078-0432.CCR-08-2150, ISSN 1078-0432, pages 1192 - 1198, XP055058423 [Y] 1-4,9-11,15 * figure 1 * DOI: http://dx.doi.org/10.1158/1078-0432.CCR-08-2150 | International search | [Y]US2007280928 (BUCK ELIZABETH A [US], et al); | [Y]US2003211521 (TAYLOR-PAPADIMITRIOU JOYCE [GB]); | [A]WO2009076775 (UNIV MCGILL [CA], et al); | [A]WO2009048282 (AMOREPACIFIC CORP [KR], et al); | [A]US2004253677 (SABATINI DAVID M [US], et al) | [Y] - YAMANE ET AL., "PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation.", MOLECULAR CELL, (2007), vol. 25, pages 801 - 812, XP008151026 DOI: http://dx.doi.org/10.1016/j.molcel.2007.03.001 | [Y] - GATTA ET AL., "NF-Y substitutes H2A-H2B on active cell-cycle promoters: recruitment of CoREST- KDM1 and fine-tuning of H3 methylations.", NUCLEIC ACIDS RESEARCH, (2008), vol. 36, no. 20, pages 6592 - 6607, XP008151027 DOI: http://dx.doi.org/10.1093/nar/gkn699 | [Y] - ROESCH ET AL., "RBP-2H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells.", INT J CANCER, (2008), vol. 122, pages 1047 - 1057, XP008151025 DOI: http://dx.doi.org/10.1002/ijc.23211 |